MARKET WIREReuters • 2h ago
Iran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz - ReutersIran's IRGC Navy says two tankers 'exploded' after hitting mines in Hormuz Reuters
Why FOCL Stock dropped -2.11% Today — RQD Quant Desk Flash
$4.17 -2.11% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $4.15
EDAP TMS S.A. (FOCL) carries a Roarable Rating of E (Strong Sell) with 29/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $191.6M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $4.15 (-0.57%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (29/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-12.9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for FOCL)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (29/100 Composite)
🔍 WHY FOCL SCORES 29/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (28% of score)
Altman Z-Score 0.20 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9
▲ #2 Bullish Driver: Whale & Options Positioning+7/20 pts (24% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$4.19-2.4% Next Q
37
Q2 (-2Q)Grade E$4.09+2% Next Q
34
Q3 (-1Q)Grade E$4.17+0% Next Q
32
CurrentGrade E$4.17-9.8% Hist 90D α
29
Trajectory: E (37) → E (29)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a FOCL Turnaround Squeeze
While FOCL currently carries a cautious 29/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.25) and Max Pain ($4.38) forces dealer call-delta covering toward $6.72.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $FOCL• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “FOCL Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why FOCL Stock dropped -2.11% Today — RQD Quant Desk Flash
EDAP TMS S.A. (FOCL) dropped -2.11% to $4.17, trading at 51% of its 52-week range ($1.82 – $6.4). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 51% of its 52-week range ($1.82 – $6.4) with RSI-14 at 47.6 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $4.17 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 42.5% gross margin and $0 annual free cash flow.
Live FOCL Headlines & Catalysts
MARKET WIRECNBC • 4h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
MARKET WIRECNBC • 4h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 5h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 7h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 7h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 8h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 8h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring FOCL)
- ✓Walkthrough of FOCL's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
FOCL // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +25.60%⚡ TESTING RESISTANCE
2026-10-30O $4.30H $4.41L $4.10C $4.17VOL 66.1K
RES: $4.40SUP: $3.96SMA50: $4.25SMA200: $4.41
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
FOCL Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +1.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on FOCL today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for FOCL. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for FOCL today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (FOCL)
Health Care Rank #957 of 1016
⚔️ ELMD vs FOCL Full Matrix →
1. Head-to-Head Health Care Peer Comparison (FOCL vs. ELMD, HSDT, VANI, CV)
Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, EDAP TMS S.A. (FOCL) ranks #957 by composite RQD confidence (29/100, grade E) and #583 by equity capitalization ($191.6M). Within this direct 5-issuer industry benchmark cohort, VANI leads on earnings valuation at 3.9x trailing P/E, while ELMD leads on capital efficiency and profitability with 24.1% ROIC and 78.1% gross margin. ELMD currently holds the highest overall quantitative score in the immediate peer group at 77/100 (B+) compared with FOCL at 29/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| FOCL
ACTIVE
EDAP TMS S.A. | E | 29/100 | — | 42.5% | -35.0% | -2.11% | $191.6M | Benchmark Subject |
| ELMD Electromed Inc. | B+ | 77/100 | 30.4x | 78.1% | 24.1% | +1.47% | $229.4M | /elmd-vs-focl → |
| HSDT Solana Company (Class A) | D- | 37/100 | — | 96.0% | -35.0% | -1.31% | $146.5M | /hsdt-vs-focl → |
| VANI Vivani Medical Inc. | E | 34/100 | 3.9x | — | -35.0% | 0.00% | $102.8M | /vani-vs-focl → |
| CV CapsoVision Inc. | D | 44/100 | — | 52.9% | -35.0% | -1.70% | $369.2M | /cv-vs-focl → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001041934In its most recent audited fiscal period (FY2025, filed 2025-12-31), EDAP TMS S.A. (FOCL) reported GAAP revenue of $70.5M (+1.6% vs. FY2024 revenue of $69.4M ) , GAAP net income of -$29.2M, operating cash flow of -$16.4M, and free cash flow of -$16.4M (-11.6% YoY). On the balance sheet, FOCL closed FY2025 with $79.0M in total assets against $15.9M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $70.5M | -$29.2M | -$16.4M | -$16.4M | $79.0M | $15.9M |
| FY2024 (FY) | 2024-12-31 | $69.4M | -$20.6M | -$14.7M | -$14.7M | $89.4M | $2.2M |
3. FOCL Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs FOCL stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, EDAP TMS S.A. (NASDAQ: FOCL) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 29/100 at a spot price of $4.17 (-2.11% 1D, market cap $191.6M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, FOCL ranks #957 in composite RQD confidence.
How does FOCL compare to ELMD and HSDT in the Health Care sector?
Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), FOCL carries a Roarable E (29/100 RQD), trailing P/E of N/A, gross margin of 42.5%, and ROIC of -35.0%. By comparison, ELMD (Electromed Inc.) holds a B+ grade (77/100 RQD, P/E 30.4x, ROIC 24.1%, cap $229.4M) and HSDT (Solana Company (Class A)) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $146.5M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).
What are the biggest fundamental strengths and SEC risk factors for FOCL?
Per FOCL's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001041934), EDAP TMS S.A. generated $70.5M in revenue (+1.6% YoY), -$29.2M in net income, and -$16.4M in free cash flow against $79.0M in total assets and $15.9M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is FOCL trading relative to its 50-day, 200-day, and 52-week technical levels?
FOCL last traded at $4.17 (-2.11% on volume of 42,117 shares), positioning the stock -1.88% below its 50-day simple moving average ($4.25) and -5.44% below its 200-day simple moving average ($4.41). Across its 52-week range of $1.82 to $6.40, FOCL sits at the 51.3% percentile with a 14-day RSI of 47.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($3.65 to $4.69).
FOCL Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is FOCL stock moving today?
Why FOCL Stock dropped -2.11% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.